FDA Work Plan Calls For 29% Drop In FY 1999 Device Facility Inspections
This article was originally published in The Gray Sheet
FDA intends to inspect 50% of domestic manufacturers producing high-risk devices in fiscal year 1999 and the remainder in FY 2000 as part of an effort to fulfill its statutory obligation to inspect such firms every two years, agency staffers say.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.